These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 18956617)

  • 1. [Domino principle--monoamines in bottom-view].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Jun; 10(3):131-40. PubMed ID: 18956617
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depression as a spreading adjustment disorder of monoaminergic neurons: a case for primary implication of the locus coeruleus.
    Harro J; Oreland L
    Brain Res Brain Res Rev; 2001 Dec; 38(1-2):79-128. PubMed ID: 11750928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin contributes to monoaminergic dysfunction and to dependent neurobehavioral comorbidities of epilepsy.
    Medel-Matus JS; Shin D; Sankar R; Mazarati A
    Exp Neurol; 2017 Mar; 289():64-72. PubMed ID: 28013000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Consequences of the monoaminergic systems cross-talk in the antidepressant activity].
    Tritschler L; Gaillard R; Gardier AM; David DJ; Guilloux JP
    Encephale; 2018 Jun; 44(3):264-273. PubMed ID: 29801770
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depression as a spreading neuronal adjustment disorder.
    Harro J; Oreland L
    Eur Neuropsychopharmacol; 1996 Aug; 6(3):207-23. PubMed ID: 8880081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of norepinephrine in depression.
    Delgado PL; Moreno FA
    J Clin Psychiatry; 2000; 61 Suppl 1():5-12. PubMed ID: 10703757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duloxetine pharmacology: profile of a dual monoamine modulator.
    Karpa KD; Cavanaugh JE; Lakoski JM
    CNS Drug Rev; 2002; 8(4):361-76. PubMed ID: 12481192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant properties of substance P antagonists: relationship to monoaminergic mechanisms?
    Adell A
    Curr Drug Targets CNS Neurol Disord; 2004 Apr; 3(2):113-21. PubMed ID: 15078186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The neuropharmacology of serotonin and noradrenaline in depression.
    Nutt DJ
    Int Clin Psychopharmacol; 2002 Jun; 17 Suppl 1():S1-12. PubMed ID: 12369606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galanin receptor antagonists : a potential novel pharmacological treatment for mood disorders.
    Ogren SO; Kuteeva E; Hökfelt T; Kehr J
    CNS Drugs; 2006; 20(8):633-54. PubMed ID: 16863269
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered presynaptic function in monoaminergic neurons of monoamine oxidase-A knockout mice.
    Owesson CA; Hopwood SE; Callado LF; Seif I; McLaughlin DP; Stamford JA
    Eur J Neurosci; 2002 May; 15(9):1516-22. PubMed ID: 12028362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoamine dysfunction and the pathophysiology and treatment of depression.
    Charney DS
    J Clin Psychiatry; 1998; 59 Suppl 14():11-4. PubMed ID: 9818625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine neurocircuitry in depression and strategies for new treatments.
    Hamon M; Blier P
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():54-63. PubMed ID: 23602950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological principles of antidepressant efficacy.
    Schatzberg AF
    Hum Psychopharmacol; 2002 Jun; 17 Suppl 1():S17-22. PubMed ID: 12404665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute effect of milnacipran on the relationship between the locus coeruleus noradrenergic and dorsal raphe serotonergic neuronal transmitters.
    Bandoh T; Hayashi M; Ino K; Takada S; Ushizawa D; Hoshi K
    Eur Neuropsychopharmacol; 2004 Dec; 14(6):471-8. PubMed ID: 15589386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects.
    Dell'Osso B; Palazzo MC; Oldani L; Altamura AC
    CNS Neurosci Ther; 2011 Dec; 17(6):723-32. PubMed ID: 21155988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The revised monoamine theory of depression: a modulatory role for monoamines, based on new findings from monoamine depletion experiments in humans.
    Heninger GR; Delgado PL; Charney DS
    Pharmacopsychiatry; 1996 Jan; 29(1):2-11. PubMed ID: 8852528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evidence and potential neurobiological underpinnings of unresolved symptoms of depression.
    Trivedi MH; Hollander E; Nutt D; Blier P
    J Clin Psychiatry; 2008 Feb; 69(2):246-58. PubMed ID: 18363453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of selective serotonin and norepinephrine reuptake inhibitors on depressive- and impulsive-like behaviors and on monoamine transmission in experimental temporal lobe epilepsy.
    Kumar U; Medel-Matus JS; Redwine HM; Shin D; Hensler JG; Sankar R; Mazarati A
    Epilepsia; 2016 Mar; 57(3):506-15. PubMed ID: 26813337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.